Mitochondrial Dysfunction and Oxidative Damage in Alzheimer's and Parkinson's Diseases and Coenzyme Q10 as a Potential Treatment

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Bioenergetics and Biomembranes

• Publication date

  2004-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1023/B:JOBB.0000041772.74810.92PMID 15377876
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells

  2003cited by this paper
• Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.

  2003cited by this paper
• Mitochondrial uncoupling protein‐2 protects the immature brain from excitotoxic neuronal death

  2003cited by this paper
• Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model.

  2003cited by this paper
• Coenzyme Q10 Prevents Apoptosis by Inhibiting Mitochondrial Depolarization Independently of Its Free Radical Scavenging Property*

  2003cited by this paper
• Oxidative stress in Parkinson's disease

  2003cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• Truncated product of the bifunctional DLST gene involved in biogenesis of the respiratory chain

  2003cited by this paper
• Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease

  2003cited by this paper
• Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease.

  2003cited by this paper
• Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma

  2003cited by this paper
• Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

  2002cited by this paper
• Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.

  2002cited by this paper
• Idebenone and reduced cardiac hypertrophy in Friedreich's ataxia

  2002cited by this paper
• Oxidative damage and cytogenetic analysis in leukocytes of Parkinson’s disease patients

  2002cited by this paper
• An In Vitro Model of Parkinson's Disease: Linking Mitochondrial Impairment to Altered α-Synuclein Metabolism and Oxidative Damage

  2002cited by this paper
• Mitochondrial DNA Deletions/Rearrangements in Parkinson Disease and Related Neurodegenerative Disorders

  2002cited by this paper
• Novel mitochondrial DNA mutations in Parkinson's disease

  2002cited by this paper
• Superoxide activates mitochondrial uncoupling proteins

  2002cited by this paper
• Oxidative stress increases expression and activity of BACE in NT2 neurons.

  2002cited by this paper
• Therapeutic Effects of Coenzyme Q10 and Remacemide in Transgenic Mouse Models of Huntington's Disease

  2002cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia

  2001cited by this paper
• Early-onset Amyloid Deposition and Cognitive Deficits in Transgenic Mice Expressing a Double Mutant Form of Amyloid Precursor Protein 695*

  2001cited by this paper
• The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

  2001cited by this paper
• β‐Amyloid inhibits integrated mitochondrial respiration 
and key enzyme activities

  2001cited by this paper
• Induction of alpha-synuclein aggregation by intracellular nitrative insult.

  2001cited by this paper
• Induction of α-Synuclein Aggregation by Intracellular Nitrative Insult

  2001cited by this paper
• Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis

  2001cited by this paper
• Mitochondrial Abnormalities in Alzheimer's Disease

  2001cited by this paper
• Metabolic enzyme expression in dopaminergic neurons in Parkinson's disease: An in situ hybridization study

  2001cited by this paper
• A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease

  2001cited by this paper
• Chronic systemic pesticide exposure reproduces features of Parkinson's disease

  2000cited by this paper
• Effect of coenzyme Q(10) on biochemical and morphological changes in experimental ischemia in the rat brain.

  2000cited by this paper
• Coenzyme Q is an obligatory cofactor for uncoupling protein function

  2000cited by this paper
• Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.

  2000cited by this paper
• A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy

  2000cited by this paper
• Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome

  2000cited by this paper
• Regulation of ubiquinone metabolism.

  2000cited by this paper
• An out‐of‐frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production

  2000cited by this paper
• Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson’s disease

  2000cited by this paper
• Selective increase in cellular Aβ42 is related to apoptosis but not necrosis

  2000cited by this paper
• Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.

  2000cited by this paper
• Selective increase in cellular A beta 42 is related to apoptosis but not necrosis.

  2000cited by this paper
• Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity

  1999cited by this paper
• Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study.

  1999cited by this paper
• Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons.

  1999cited by this paper
• Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation

  1999cited by this paper
• The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease.

  1998cited by this paper
• Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.

  1998cited by this paper
• Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.

  1998cited by this paper
• Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein

  1998cited by this paper
• Protein Nitration in Parkinson's Disease

  1998cited by this paper
• Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease

  1998cited by this paper
• Increased Oxidative Damage Is Correlated to Altered Mitochondrial Function in Heterozygous Manganese Superoxide Dismutase Knockout Mice*

  1998cited by this paper
• Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

  1998cited by this paper
• The amyloid beta protein induces oxidative damage of mitochondrial DNA.

  1997cited by this paper
• A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia

  1997cited by this paper
• A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.

  1997cited by this paper
• A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

  1997cited by this paper
• A Generalised Increase in Protein Carbonyls in the Brain in Parkinson's but Not Incidental Lewy Body Disease

  1997cited by this paper
• Presenilin-1 is associated with Alzheimer's disease amyloid.

  1997cited by this paper
• The Amyloid β Protein Induces Oxidative Damage of Mitochondrial DNA

  1997cited by this paper
• Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases.

  1997cited by this paper
• Energy metabolism defects in Huntington's disease and effects of coenzyme Q10

  1997cited by this paper
• Altered Calcium Homeostasis in Cells Transformed by Mitochondria from Individuals with Parkinson's Disease

  1997cited by this paper
• Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

  1997cited by this paper
• Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease.

  1996cited by this paper
• Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

  1996cited by this paper
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

  1996cited by this paper
• Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Origin and functional consequences of the complex I defect in Parkinson's disease

  1996cited by this paper
• Assessment of coenzyme q10 tolerability in huntington's disease

  1996cited by this paper
• Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

  1996cited by this paper
• Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.

  1995cited by this paper
• Suppression of Mitochondrial Succinate Dehydrogenase, a Primary Target of β‐Amyloid, and Its Derivative Racemized at Ser Residue

  1995cited by this paper
• Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro

  1995cited by this paper
• Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria.

  1994cited by this paper
• Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death.

  1994cited by this paper
• Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease.

  1994cited by this paper
• Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

  1994cited by this paper
• Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate

  1994cited by this paper
• Abnormality of the α‐ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease

  1994cited by this paper
• Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease.

  1994cited by this paper
• Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study

  1994cited by this paper
• Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative.

  1994cited by this paper
• Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

  1993cited by this paper
• A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid

  1992cited by this paper
• An analysis of the role of coenzyme Q in free radical generation and as an antioxidant.

  1992cited by this paper
• Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease.

  1992cited by this paper
• Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease.

  1992cited by this paper
• Ubiquinone Protects Cultured Neurons against Spontaneous and Excitotoxin-Induced Degeneration

  1992cited by this paper
• Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

  1991cited by this paper
• Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease

  1991cited by this paper
• Mitochondrial complex I deficiency in Parkinson's disease.

  1989cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

  1989cited by this paper
• Mitochondrial function in Parkinson's disease.

  1989cited by this paper
• Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

  1989cited by this paper

• Potential Roles of Natural Antioxidants in Modulating Neurodegenerative Disease Pathways

  2025cites this paper
• Coenzyme Q10 and its Therapeutic Effect on Tinnitus

  2025cites this paper
• Advanced Biomarkers: Beyond Amyloid and Tau: Emerging Non-Traditional Biomarkers for Alzheimer's Diagnosis and Progression.

  2025cites this paper
• The Effect of Coenzyme Q10 on Tinnitus Severity and Sleep Quality in Patients with Presbycusis

  2025cites this paper
• Effects of Pretreatment With Coenzyme Q10 (CoQ10) and High‐Intensity Interval Training (HIIT) on FNDC5, Irisin, and BDNF Levels, and Amyloid‐Beta (Aβ) Plaque Formation in the Hippocampus of Aβ‐Induced Alzheimer's Disease Rats

  2025cites this paper
• The Metabolic Profile of Plasma During Epileptogenesis in a Rat Model of Lithium–Pilocarpine-Induced Temporal Lobe Epilepsy

  2025cites this paper
• The GPCR NMUR-1 mediates neural regulation of energy homeostasis in response to pathogen infection

  2025cites this paper
• Bioactivity and Neuroprotective Effects of Extra Virgin Olive Oil in a Mouse Model of Cerebral Ischemia: An In Vitro and In Vivo Study

  2025cites this paper
• Oxidative damage in neurodegeneration: roles in the pathogenesis and progression of Alzheimer disease.

  2024cites this paper
• Enhancement of in-vivo cellular uptake of Coenzyme Q10 using saponin derivatives in rTALAP transgenic mice model

  2024cites this paper
• Protective effects of geraniol in a male rat model of Alzheimer's disease: A behavioral, biochemical, and histological study

  2024cites this paper
• Artificial Intelligence in Parkinson's Disease: Early Detection and Diagnostic Advancements.

  2024cites this paper
• Molecular mechanisms of mitochondrial homeostasis regulation in neurons and possible therapeutic approaches for Alzheimer's disease

  2024cites this paper
• Neuronal GPCR NMUR-1 regulates energy homeostasis in response to pathogen infection

  2024cites this paper
• Assessing the performance of Coenzyme Q10 loaded DQAsomes to treat Leigh syndrome caused by NDUFS4 knockout

  2024cites this paper
• CoQ10 and Mitochondrial Dysfunction in Alzheimer’s Disease

  2024cites this paper
• Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article

  2023cites this paper
• Coenzyme Q10 and Dementia: A Systematic Review

  2023cites this paper
• Cognitive Enhancing Activities of Coenzyme Q10, Ramipril, and Vinpocetine Through Modulating Neuroinflammatory Response and Oxidative Damage Inflicted by Acute REM Sleep Deprivation in Rats

  2023cites this paper
• Oxidative stress, inflammation, dysfunctional redox homeostasis and autophagy cause age-associated diseases

  2023cites this paper
• The neuroprotective roles of Dietary Micronutrients on Parkinson’s disease: a review

  2022cites this paper
• Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update

  2022cites this paper
• Therapeutics of Alzheimer’s Disease: Recent Developments

  2022influential citation
• Reducing the risk of death induced by aluminum phosphide poisoning: The new therapies.

  2022cites this paper
• Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review

  2022cites this paper
• Avaliação da administração de coenzima Q10 na atenuação de respostas oxidativas da agregação β-Amiloide em modelos de doença de Alzheimer: Uma revisão sistemática de literatura

  2021cites this paper
• Improvement of Oxidative Stress and Mitochondrial Dysfunction by β-Caryophyllene: A Focus on the Nervous System

  2021cites this paper
• Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease

  2021cites this paper
• Imbalanced autophagy causes synaptic deficits in a human model for neurodevelopmental disorders

  2021cites this paper
• Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective

  2020cites this paper
• p-Benzoquinone a privileged scaffold of pharmacological significance: A review.

  2020cites this paper
• Effects of Higher Serum Lipid Levels on the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis

  2020cites this paper
• Therapeutic Strategies for Regulating Mitochondrial Oxidative Stress

  2020cites this paper
• Coenzyme Q10 supplementation reverses diabetes-related impairments in long-term potentiation induction in hippocampal dentate gyrus granular cells: an in vivo study.

  2020cites this paper
• Naturally occurring neuroprotectants in glaucoma.

  2020cites this paper
• Inhibitory potential of plant secondary metabolites on anti-Parkinsonian drug targets: Relevance to pathophysiology, and motor and non-motor behavioural abnormalities.

  2020cites this paper
• Metabolic Dysregulation Contributes to the Progression of Alzheimer’s Disease

  2020cites this paper
• Methylene blue reduces incidence of early postoperative cognitive disorders in elderly patients undergoing major non-cardiac surgery: An open-label randomized controlled clinical trial.

  2020cites this paper
• KANSL1 Deficiency Causes Neuronal Dysfunction by Oxidative Stress-Induced Autophagy

  2020cites this paper
• Four-Repeat Tauopathies: Current Management and Future Treatments

  2020cites this paper
• Effect of coenzyme Q10 supplementation on diabetes induced memory deficits in rats

  2019cites this paper
• Neurodegenerative Diseases and Their Therapeutic Approaches

  2019cites this paper
• PET imaging of 11C-labeled coenzyme Q10: Comparison of biodistribution between [11C]ubiquinol-10 and [11C]ubiquinone-10.

  2019cites this paper
• Targeting Mitochondria in Alzheimer Disease: Rationale and Perspectives

  2019cites this paper
• Development of highly water-dispersible complexes between coenzyme Q10 and protein hydrolysates.

  2019cites this paper
• Coenzyme Q10

  2019cites this paper
• Investigation of protective effects of coenzyme Q10 on impaired synaptic plasticity in a male rat model of Alzheimer's disease.

  2019cites this paper
• Preparation and characterization of coenzyme Q10 loaded solid lipid-based formulations for enhancement of gastrointestinal solubilization

  2018cites this paper
• CoQ10 a super-vitamin: review on application and biosynthesis

  2018cites this paper
• Age-Dependent Loss of Mitochondrial Function in Epithelial Tissue Can Be Reversed by Coenzyme Q10

  2018cites this paper
• Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer’s disease

  2018cites this paper
• Perspectives on Oxidative Stress in Alzheimer’s Disease and Predictions of Future Research Emphases

  2018cites this paper
• Paraquat-Induced Movement Disorder in Relation to Oxidative Stress-Mediated Neurodegeneration in the Brain of Drosophila melanogaster

  2017cites this paper
• Phenolic amides with anti-Parkinson’s disease (PD) effects from Nicandra physaloides

  2017cites this paper
• Different Q 10-Formulations Result in an Increase in the Fast Beta-Domain of the EEG

  2017cites this paper
• Packaging of the Coenzyme Q10 into a Liposome for Mitochondrial Delivery and the Intracellular Observation in Patient Derived Mitochondrial Disease Cells.

  2017cites this paper
• Neuroprotective Effects of a Novel Antioxidant Mixture Twendee X in Mouse Stroke Model.

  2017cites this paper
• L-carnitine contributes to enhancement of neurogenesis from mesenchymal stem cells through Wnt/β-catenin and PKA pathway

  2017cites this paper
• Confounding of the association between statins and Parkinson disease: systematic review and meta‐analysis

  2017cites this paper
• Correction to: Paraquat-Induced Movement Disorder in Relation to Oxidative Stress-Mediated Neurodegeneration in the Brain of Drosophila melanogaster

  2017influential citation
• Structural insights into the methyl donor recognition model of a novel membrane-binding protein UbiG

  2016cites this paper
• Catalytic Formation of Hydrogen Peroxide from Coenzyme NADH and Dioxygen with a Water-Soluble Iridium Complex and a Ubiquinone Coenzyme Analogue.

  2016cites this paper
• Neuroregeneration: Disease Modeling and Therapeutic Strategies for Alzheimer’s and Parkinson’s Diseases

  2016cites this paper
• Vitamin Q10 : Property, Production and Application

  2016cites this paper
• Hybrids: a new paradigm to treat Alzheimer’s disease

  2016cites this paper
• Nutraceuticals against Neurodegeneration: A Mechanistic Insight

  2016cites this paper
• Coenzyme Q and Its Role in the Dietary Therapy against Aging

  2016cites this paper
• Regulation of pancreatic β-cell death and cancer cell migration by TPRM2 channels

  2016cites this paper
• Changes within the Electroencephalogram and Increase in Mental Concentration are related to Differences in Solubulisation and Composition of Different Q10-Formulations

  2016cites this paper
• Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications.

  2016cites this paper
• Controlled and Impaired Mitochondrial Quality in Neurons: Molecular Physiology and Prospective Pharmacology.

  2015cites this paper
• Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine.

  2015cites this paper
• Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants.

  2015cites this paper
• Bioactive Substances of Animal Origin

  2015cites this paper
• Parkinson's disease: in vivo brain metabolomics by MRS.

  2015cites this paper
• Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants

  2015cites this paper
• Statins, plasma cholesterol, and risk of Parkinson's disease: A prospective study

  2015cites this paper
• Protective role of coenzyme Q10 as a means of alleviating the toxicity of aluminum phosphide: An evidence-based review

  2015cites this paper
• A tripeptide isolated from Bothrops atrox venom has neuroprotective and neurotrophic effects on a cellular model of Parkinson's disease.

  2015cites this paper
• Cytochrome b5 reductase, a plasma membrane redox enzyme, protects neuronal cells against metabolic and oxidative stress through maintaining redox state and bioenergetics

  2015cites this paper
• Identification and elimination of metabolic bottlenecks in the quinone modification pathway for enhanced coenzyme Q10 production in Rhodobacter sphaeroides.

  2015cites this paper
• Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.

  2015cites this paper
• Ubiquinone-10 alters mechanical properties and increases stability of phospholipid membranes.

  2015cites this paper
• Influence of Triphenylphosphonium (TPP) Cation Hydrophobization with Phospholipids on Cellular Toxicity and Mitochondrial Selectivity

  2015cites this paper
• Mitochondrial respiration deficits driven by reactive oxygen species in experimental temporal lobe epilepsy.

  2015cites this paper
• Effect of Coenzyme Q10 Supplementation on Markers of Oxidative Stress in Streptozotocin Induced Diabetic Rats

  2014cites this paper
• International Journal for Pharmaceutical Research Scholars (IJPRS)

  2014cites this paper
• Antioxidant SkQ1 delays sarcopenia-associated damage of mitochondrial ultrastructure

  2014cites this paper
• Coenzyme Q10 treatment ameliorates cognitive deficits by modulating mitochondrial functions in surgically induced menopause.

  2014cites this paper
• Neuroprotective Effect of Coenzyme Q10 in Hippocampal Injury in Balb/c Mouse

  2014cites this paper
• Proteomic Analysis of Serum Proteins in Triple Transgenic Alzheimer's Disease Mice: Implications for Identifying Biomarkers for Use to Screen Potential Candidate Therapeutic Drugs for Early Alzheimer's Disease

  2014cites this paper
• Redox Status and Aging Link in Neurodegenerative Diseases

  2014cites this paper
• Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A2A receptor levels in rats subjected to neuroinflammation

  2014cites this paper
• Mitochondrial dysfunction: cause and consequence of Alzheimer's disease.

  2014cites this paper
• Nrf2 activation as a future target of therapy for chronic diseases

  2014cites this paper
• Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases.

  2014cites this paper
• Challenges in Designing Therapeutic Agents for Treating Alzheimer’s Disease-from Serendipity to Rationality

  2014cites this paper
• Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity.

  2014cites this paper
• Rôle de la dysfonction mitochondriale dans deux maladies neurodégénératives, la Maladie de Huntington et la Maladie de Parkinson

  2014cites this paper
• Development of Dual-Electrode Amperometric Detectors for Liquid Chromatography and Capillary Electrophoresis

  2013cites this paper